Paradromics Inc.

The scope of unmet medical needs in mental health is vast. For many of these conditions, biological cures may take decades. By providing a means of directly accessing the brain, Direct Data Interfaces provide a path to therapies for complex biological problems with no known cure.

We are one of two companies with the capability to build high data rate brain computer interfaces. We have raised $140M to date, including $14M from DARPA.

• 
  FDA approves Paradromics’ brain-computer interface trial for speech restoration

  STAT · Nov 20, 2025

  Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

• 
  BCI Developer Paradromics Raises $20 mln in Fresh Funding - Grit Daily News

  Grit Daily News · Aug 1, 2021

  Paradromics, a company focused on developing high data rate Brain-Computer Interfaces (BCI), has announced a fundraising of $20 million.

• 
  Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA

  www.prnewswire.com

  /PRNewswire/ -- Paradromics Inc., the leading developer of high data-rate brain-computer interfaces (BCI), today announced a $33 million Series A funding round...